Quantum-Si incorporated
Financials
Valuation Metrics
Quantum-Si incorporated's Market Cap is $274M. At end of 2025 it was $218M. Ranked #2891 of 3,118 in US market (top 93%), #1300 of 1,474 on NASDAQ (top 88%), #232 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 88%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $274M | US#2,891/3,118 Sec#232/265 |
| Revenue | $2M | US#2,840/3,118 Sec#186/265 |
| Net Income | $-99M | US—/3,118 Sec—/265 |
| Total Assets | $194M | US#2,987/3,118 Sec#244/265 |
| Net Assets | $180M | US#2,703/3,118 Sec#196/265 |
| Employees | 145 | US#2,542/3,118 Sec#147/265 |
| Value | ||
| P/B | 1.52x | US#1,102/3,118 Sec#49/265 |
| P/S | 170.95x | US#2,956/3,118 Sec#185/265 |
| FCF Yield | -34.15% | US—/3,118 Sec—/265 |
| Profitability | ||
| ROE | -54.67% | US#2,690/3,118 Sec#163/265 |
| ROA | -50.89% | US#2,987/3,118 Sec#217/265 |
| Op. Margin | -5929.72% | US#2,835/3,118 Sec#180/265 |
| Revenue Growth | -52.96% | US#2,697/3,118 Sec#159/265 |
| Financial Health | ||
| Debt Ratio | 7.42% | US#67/3,118 Sec#33/265 |
| Total Debt | $3M | US#2,922/3,118 Sec#226/265 |
| FCF | $-94M | US#2,622/3,118 Sec#139/265 |
| Cash | $24M | US#2,817/3,118 Sec#252/265 |
| Current Ratio | 9.97x | US#246/3,118 Sec#77/265 |
| Performance | ||
| 1Y Return | -41.40% | US#2,567/3,118 Sec#203/265 |
| 1M Return | -18.71% | US#45/3,118 Sec#8/265 |
| From 52W High | -35.38% | US#2,105/3,118 Sec#140/265 |
| 1Y MDD | -61.83% | US#2,841/3,118 Sec#222/265 |
| Trading | ||
| Volume | 8,037,107 shares | US#195/3,118 Sec#8/265 |
| Trading Value | $11M | US#2,092/3,118 Sec#158/265 |
| Per Share | ||
| EPS | $-0.45 | US—/3,118 Sec—/265 |
| BPS | $0.83 | US#2,715/3,118 Sec#206/265 |
Company Info
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.